Condições
18 condições de saúde com pesquisa de suplementos baseada em evidências
Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.
How We Grade Evidence
Cada página de condição classifica os ingredientes de suplementos pela força da evidência clínica. Veja o que cada nota significa:
Strong Evidence
Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.
Good Evidence
At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.
Some Evidence
Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.
Very Early Research
In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.
Acute Bronchitis
5% of adults annually
Allergic Rhinitis
10-30% of adults globally; 40% of children
Gut Immune Health
Gut dysbiosis affects an estimated 25-45% of adults
Post-Viral Fatigue
10-35% of individuals after certain viral infections; ~10% post-COVID
Chronic Inflammation
Estimated 50-60% of adults have at least one inflammatory biomarker elevation
Recurrent Infections
~25% of primary care patients report recurrent infections
Oxidative Stress
Universal physiological process; pathological levels associated with chronic disease
Stress-Related Immune Suppression
Chronic stress affects 70-80% of working adults
Vaccine Response Support
Suboptimal vaccine responses in 30-50% of elderly adults
Pediatric Immune Support
6-8 URTIs per year in children under 6
Exercise-Induced Immune Suppression
Affects endurance athletes and those in heavy training
Sinusitis
31 million episodes annually in the US
Wound Healing and Immune Recovery
50 million surgical procedures annually in the US require immune recovery support
Skin Immune Barrier
Compromised skin barrier affects 15-20% of adults (eczema, dermatitis)
Upper Respiratory Tract Infections
2-4 episodes/year in adults; 6-8 in children
Influenza
5-15% of global population annually
Immune Aging (Immunosenescence)
Affects all individuals with aging; clinically significant after age 65
Autoimmune Conditions
5-8% of the population; >80 recognized autoimmune diseases
Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.